Obituary: Hans Gombotz (1948–2021)
After a long battle with cancer and in his 73rd year, Professor Hans Gombotz passed away on September 13, 2021. We are mourning over the loss of a brilliant scientist, […]
Category: News
Patient Blood Management is not about blood transfusion: it is about patients’ outcomes
In an editorial published in Blood Transfusion, Thomas Frietsch, Aryeh Shander, David Faraoni and Jean-Francois Hardy comment on the results of the Frankfurt Consensus Conference on Patient Blood Management (Müller MM et […]
Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement
Postpartum haemorrhage remains a common obstetric emergency and is the leading cause for maternal mortality worldwide. The aim of this multidisciplinary consensus statement is to provide recommendations on the prevention […]
Management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement
This multidisciplinary consensus statement, which was published in the February 2018 issue of Transfusion Medicine with open access, provides recommendations on the management of anaemia and haematinic deficiencies in pregnancy and in […]
AAGBI guidelines: the use of blood components and their alternatives 2016
This consensus document, published in the July issue of Anaesthesia, was produced by members of a Working Party established by the Association of Anaesthetists of Great Britain and Ireland (AAGBI). The […]
European Medicines Agency’s Committee for Medicinal Products for Human Use recommends marketing authorisation for idarucizumab (Praxbind), a specific reversal agent for dabigatran
On 24 September 2015, the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product […]
Anaesthesia Supplement on ‘Transfusion, Thrombosis and Management of Bleeding’
Anaesthesia, the journal of the Association of Anaesthetists of Great Britain & Ireland, announces the publication of a special open-access supplement on Transfusion, Thrombosis and Management of Bleeding, to coincide with […]
Akebia Announces Dosing of First Patient in Phase 2 Study of AKB-6548 in Patients with Anemia Related to Chronic Kidney Disease Undergoing Dialysis
On September 25, 2014, Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products […]
Antidote for rapid reversal of Pradaxa® (dabigatran etexilate) progresses into next stage of clinical investigation with study in patients
On May 22, 2014, Boehringer Ingelheim announced the next step in the clinical development of idarucizumab, an investigational antidote for rapid reversal of dabigatran-induced anticoagulation. Prior clinical research of the […]
Transfusion Medicine Becomes NATA’s Official Journal
Since the publication of Transfusion Alternatives in Transfusion Medicine, edited by Prof. Konrad Messmer, was stopped end of 2012, NATA did not have an official journal. The NATA board of directors […]
ASH Choosing Wisely® Campaign Recommends Avoiding Liberal RBC Transfusion
Choosing Wisely® is a medical stewardship and quality improvement initiative led by the American Board of Internal Medicine (ABIM) Foundation in collaboration with leading medical societies in the United States. […]
ANZSBT/NATA Perioperative Patient Blood Management Symposium
A one-day symposium on Perioperative Patient Blood Management will be held on October 19, 2013 at the Gold Coast Convention & Exhibition Centre in Queensland, Australia, before the the Annual […]
Ferric Carboxymaltose Receives US FDA Approval for the Treatment of Iron Deficiency Anemia
On July 25, 2013, American Regent Inc., a subsidiary of Luitpold Pharmaceuticals Inc., announced that Injectafer® (ferric carboxymaltose injection) has received U.S. Food and Drug Administration (FDA) approval. Injectafer® is […]
European Medicines Agency’s Pharmacovigilance Risk Assessment Committee Recommends Suspending Marketing Authorizations for Infusion Solutions Containing Hydroxyethyl Starch
On June 14, 2013, following a review of the available evidence, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded that the benefits of infusion solutions containing hydroxyethyl starch […]
UK Guidelines on the Management of Anemia and Red Cell Transfusion in Adult Critically Ill Patients
In the February 2013 issue of the British Journal of Haematology, Retter et al. summarize the current literature guiding the use of red cell transfusion in critically ill patients and provide recommendations to […]